The relationship between Vitamin D levels and nondipper hypertension

Blood Pressure Monitoring

Volumn 20, Issue 6, 2015, Pages 330-334

  Yilmaz, Samet ^a   Sen, Fatih ^b   Ozeke, Ozcan ^b   Temizhan, Ahmet ^b   Topaloglu, Serkan ^b   Aras, Dursun ^b   Aydogdu, Sinan ^b  

^a Yozgat State Hospital   (Turkey)

^b Yuksek Ihtisas Education and Research Hospital   (Turkey)

Author keywords

Dipper hypertension; Nondipper hypertension; Vitamin D

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN; VITAMIN D;

ADULT; ARTICLE; BLOOD ANALYSIS EQUIPMENT; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITOR; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; NONDIPPER HYPERTENSION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; PATHOPHYSIOLOGY;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VITAMIN D;

EID: 84947068629     PISSN: 13595237     EISSN: 14735725     Source Type: Journal    
DOI: 10.1097/MBP.0000000000000146     Document Type: Article

References (35)

1. Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 2011; 29:636-645.
2. Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009; 27:1948-1954.
3. Pilz S, Tomaschitz A. Role of vitamin D in arterial hypertension. Expert Rev Cardiovasc Ther 2010; 8:1599-1608.
4. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010; 55:1283-1288.
5. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, März W. Independent association between 1, 25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 2010; 411:1354-1360.
6. Vaidya A, Forman JP, Hopkins PN, Seely EW, Williams JS. 25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians. J Renin Angiotensin Aldosterone Syst 2011; 12:311-319.
7. Brewer LC, Michos ED, Reis JP. Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets 2011; 12:54-60.
8. Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 2012; 25:1215-1222.
9. Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 2013; 61:779-785.
10. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 2012; 97:3557-3568.
11. Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, et al. Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med 2015; 175:745-754.
12. O' Brien E, Sheridan J, O' Malley K. Dippers and non-dippers. Lancet 1988; 21:394-397.
13. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and non-dippers. Circulation 1990; 81:700-702.
14. Izzedine H, Launay-Vacher V, Deray G. A bnormal blood pressure circadian rhythm: a target organ damage? Int J Cardiol 2006; 107:343-349.
15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
16. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
17. Lavie CJ, DiNicolantonio JJ, Milani RV, O'Keefe JH. Vitamin D and cardiovascular health. Circulation 2013; 128:2404-2406.
18. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801.
19. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275:1571-1576.
20. De la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, et al. Spanish Society of Hypertension Ambulatory Blood Pressure Monitoring Registry Investigators. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 2009; 53:466-472.
21. Mann S, Altman DG, Raftery EB, Bannister R. Circadian variation of blood pressure in autonomic failure. Circulation 1983; 68:477-483.
22. Sherwood A, Steffen PR, Blumenthal JA, Kuhn C, Hinderliter AL. Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens 2002; 15 (Pt 1):111-118.
23. Sherwood A, Routledge FS, Wohlgemuth WK, Hinderliter AL, Kuhn CM, Blumenthal JA. Blood pressure dipping: ethnicity, sleep quality, and sympathetic nervous system activity. Am J Hypertens 2011; 24:982-988.
24. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007; 20:713-719.
25. Zhao G, Ford ES, Li C, Kris-Etherton PM, Etherton TD, Balluz LS. Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults. J Hypertens 2010; 28:1821-1828.
26. Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283, 537 participants. Eur J Epidemiol 2013; 28:205-221.
27. Zhao G, Ford ES, Li C, Croft JB. Serum 25-hydroxyvitamin D levels and all cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens 2012; 30:284-289.
28. Tutal E, Sayin B, Ertugrul DT, Ibis A, Sezer S, Ozdemir N. Is there a link between hyperuricemia, morning blood pressure surge, and non dipping blood pressure pattern inmetabolic syndrome patient? Int J Nephrol Renovasc Dis 2013; 26:71-77.
29. Sunbul M, Gerin F, Durmus E, Kivrak T, Sari I, Tigen K, Cincin A. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens 2014; 36:217-221.
30. Arora P, Song Y, Dusek J, Plotnikoff G, Sabatine MS, Cheng S, et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation 2015; 131:254-262.
31. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152:307-314.
32. Witham MD, Price RJ, Struthers AD, Donnan PT, Messow CM, Ford I, McMurdo ME. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med 2013; 173:1672-1679.
33. Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 2012; 188:2127-2135.
34. Caprio M, Mammi C, Rosano GM. Vitamin D: a novel player in endothelial function and dysfunction. Arch Med Sci 2012; 8:4-5.
35. Mann MC, Exner DV, Hemmelgarn BR, Hanley DA, Turin TC, MacRae JM, Ahmed SB. The VITAH trial vitamin D supplementation and cardiac autonomic tone in hemodialysis: a blinded, randomized controlled trial. BMC Nephrol 2014; 15:129.